Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome

American Journal of Clinical Pathology

Volumn 114, Issue 3, 2000, Pages 419-425

  Bordi, C ^a   Azzoni, C ^a   Ferraro, G ^a   Corleto, V D ^a   Gibril, F ^a   Delle Fave, G ^a   Lubensky, I A ^a   Venzon, D J ^a   Jensen, R T ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Biopsy sampling; ECL cells; Endoscopy; Enterochromaffin like cells; Gastric carcinoids; Multiple endocrine neoplasia, type 1; Zollinger Ellison syndrome

Indexed keywords

ARTICLE; CARCINOID; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENTEROCHROMAFFIN CELL; GASTROSCOPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH BIOPSY; ZOLLINGER ELLISON SYNDROME;

EID: 0034515856     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/114.3.419     Document Type: Article

References (33)

1. Clinical implications of hypergastrinemia
2. Clinical significance of hypergastrinaemia: Relevance to gastrin monitoring during omeprazole therapy
3. The achlorhydria-carcinoid sequence: Role of gastrin
4. Is chronic long-term inhibition of gastric secretion really dangerous?
5. Risks of hypergastrinemia
6. Safety of proton pump inhibitors: An overview
7. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis
8. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
9. Toxicological studies on omeprazole
10. The ECL cells
11. Hypergastrinemia and gastric enterochromaffin-like cells
12. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study
13. Endocrine tumours of the stomach
14. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like cell proliferations of the gastric mucosa: Classification and histogenesis
15. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I
16. Gastric carcinoids in rats treated with inhibitors of gastric acid secretion
17. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach
18. 2-receptor blockade
19. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: The best approach
20. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study
21. Endocrine cell growths in atrophic body gastritis: Critical evaluation of a histological classification
22. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome: Correspondence with light microscopic findings
23. Ultrastructural morphometry of gastric endocrine cells
24. Histopathological classification of nonantral gastric endocrine growths in man
25. 2 tests
26. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth
27. Controlled clinical trials of omeprazole in the long-term management of reflux disease
28. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome
29. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer
30. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells
31. Influence of multiple endocrine neoplasia type-1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome
32. Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G cell hyperfunction